Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Apr. 30, 2022
Apr. 30, 2021
Operating activities    
Net loss $ (25,963,350) $ (33,371,690)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 194,700 172,074
Amortization of right-of-use asset 564,102 626,486
Stock-based compensation 1,272,273 3,213,750
Common stock issued for services 42,500 340,000
Foreign currency exchange (gain) loss, net 399,338 (187,039)
Gain on extinguishment of debt (960,790)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 1,561,333 681,630
Other long-term assets (290,876) (28)
Accounts payable and accrued liabilities (2,432,847) (3,458,989)
Accrued compensation related 22,226 (36,343)
Operating lease liabilities (591,579) (406,462)
Net cash used in operating activities (25,222,180) (33,387,401)
Investing activities    
Purchase of property and equipment (244,857) (259,662)
Purchase of intangible assets (495,000)
Net cash used in investing activities (244,857) (754,662)
Financing activities    
Proceeds from issuance of common stock through ESPP 1,185 5,798
Proceeds from issuance of common stock 57,004,411
Payment of financing and offering costs (15,500) (4,434,441)
Proceeds from exercise of warrants 4,792,951
Proceeds from exercise of stock options 202,800 489,580
Purchase of shares under CGP and Sirtex stock purchase agreements 5,836,731
Proceeds from co-promotion agreement 5,000,000
Principal payments on note payable (1,109,378) (497,319)
Tax withholdings paid on equity awards (43,383) (53,438)
Tax shares sold to pay for tax withholdings on equity awards 42,949 54,191
Net cash provided by (used in) financing activities (921,327) 68,198,464
Effect of exchange rate changes on cash and cash equivalents (85,376) (18,362)
Net increase (decrease) in cash and cash equivalents (26,473,740) 34,038,039
Cash and cash equivalents, at beginning of period 45,951,233 20,354,462
Cash and cash equivalents, at end of period 19,477,493 54,392,501
Supplemental disclosure for cash flow information:    
Interest 16,128 7,032
Income taxes 2,950 4,492
Noncash investing and financing transactions:    
Expiration of warrants 242,143
Increase in right-of-use assets and operating lease liabilities resulting from contract modification $ 338,819